SEC Form 4 · accession 0001387131-17-003459
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Toland
Officer — President and CEO · Director
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 9:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock option (right to buy)F1 | $0.705 | Jun 22, 2017 | A | 297,335 | A | Jun 22, 2017 | Nov 30, 2026 | Common Stock | 297,335 | 297,335 | D |
Explanation of responses
- F1Mr. Toland was granted this performance-based option on March 7, 2016 pursuant to his Employment Agreement dated February 23, 2016. The option vested in full on June 22, 2017 upon the Board's determination that Mr. Toland achieved the required performance criteria, which was the successful launch of the CorPath GRX System.